New agents are in development, but none represent a magic bullet for the problems that CRE infections present.
ANN MARIE PORRECA, PHARMD, BCPS
Advertisement
Articles by ANN MARIE PORRECA, PHARMD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves Ensitrelvir as First Oral Postexposure Prevention Option for COVID-19
2
Aging With HIV: Managing Comorbidities in a Population That Has Outlived Its Prognosis
3
Migration Trends Demonstrate Rare, But Increasing Malaria Cases in New York City
4
Ciprofloxacin, Levofloxacin, and Moxifloxacin: A Clinical Comparison of Fluoroquinolone Safety and Use
5